USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Spectranetics
Address:
96 Talamine Court
Colorado Springs, CO 80907
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $147,645.00 3

Award List:

OPTIMIZATION OF A CLEAN XECL LASER WITH A CRYOGENIC CLEAN-UP SYSTEM

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$49,216.00
Agency / Branch:
DOD / NAVY
Principal Investigator:
Robert A Golobic
Abstract:
As a contribution to the navy's satellite laser communications program, we propose to optimize laser reliability by implementing a cryogenic gas processing system during a laser lifetest. the expected lifetime to 10% energy reduction should be greater than 100 million shots. we will gather data on… More

DETERMINATION OF CONTAMINATION SOURCES IN A HIGH CLEANLINESS XENON-CHLORIDE LASER

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$48,479.00
Agency / Branch:
DOD / NAVY
Principal Investigator:
Robert A Golobic
Abstract:
As a crucial step in the process of designing a reliable, long-life xenon-chloride laser for the navy's satellite laser communications program, we propose to determine the causes of laser gas and window contamination on an already "clean" laser. we will gather quantitative data on gas composition… More

Enhanced Laser Energy Delivery by Catheter Multiplexing

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$49,950.00
Agency:
HHS
Principal Investigator:
Christopher Reiser
Abstract:
The occurrence of arterial dissection associated with percutaneous excimer laser coronary angioplasty (PELCA) is a significant technical consideration that may limit medical applications. By developing a system of sequential fiber activation for fiber optic catheters, in which only a portion of the… More